Live symbol workspace

ENOV market intelligence

Chart, AI analysis, key levels, technical analysis, sentiment, and market news are grouped so the next action is always visible.

Current $24.19

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$22.98

Resistance

$25.40

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Analysis

HOLD

Entry $24.19

Stop $22.98

Target $25.40

RSI: 50 | Current: $24.19

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

No prior-week baseline yet

Avg confidence across 2 calls in the last 7 days

What sources say

No news-sourced AI calls in the last 30 days.

Insider Trading

Refreshing insider trades from FinViz…

Technical Signals

Refreshing technical signals from FinViz…

ENOV News Intelligence (1 articles)

AI-curated news influencing ENOV price, sentiment, and trend

Explore All ENOV News with AI Analysis

Economy

2 hours, 59 minutes ago

ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?

Enovis develops orthopedic and rehabilitation devices for healthcare providers, serving a broad spectrum of musculoskeletal patient needs.

Impact on ENOV: The increased stake by Front Street could lead to a short-term positive …

Front Street has increased its stake in Enovis by purchasing 384K more shares in Q1, … Medium (60%)

View full analysis →

Yahoo Finance 60% confidence